Aspire BioPharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
Net Income | -243 | -96 | -76 | -65 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -495 | 265 | -264 | |
Cash | 16 | 19 | 11 | |
Basic Shares | 45,937 | 45,937 | 45,937 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | 0 | 0 |
Net Income | -359 | -597 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | 11 | -5,038 |
Cash | 11 | |
Basic Shares | 45,937 | 45,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.06 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.27 |
2023-12-31 | -$0.01 |
